148 related articles for article (PubMed ID: 22271434)
1. Different expression of CD146 in human normal and osteosarcoma cell lines.
Schiano C; Grimaldi V; Casamassimi A; Infante T; Esposito A; Giovane A; Napoli C
Med Oncol; 2012 Dec; 29(4):2998-3002. PubMed ID: 22271434
[TBL] [Abstract][Full Text] [Related]
2. Dysregulation of macrophage polarization is associated with the metastatic process in osteosarcoma.
Dumars C; Ngyuen JM; Gaultier A; Lanel R; Corradini N; Gouin F; Heymann D; Heymann MF
Oncotarget; 2016 Nov; 7(48):78343-78354. PubMed ID: 27823976
[TBL] [Abstract][Full Text] [Related]
3. Human osteosarcoma cells express functional receptor activator of nuclear factor-kappa B.
Mori K; Le Goff B; Berreur M; Riet A; Moreau A; Blanchard F; Chevalier C; Guisle-Marsollier I; Léger J; Guicheux J; Masson M; Gouin F; Rédini F; Heymann D
J Pathol; 2007 Apr; 211(5):555-562. PubMed ID: 17323424
[TBL] [Abstract][Full Text] [Related]
4. Different expression pattern of cytokine receptors by human osteosarcoma cell lines.
Lisignoli G; Toneguzzi S; Cattini L; Pozzi C; Facchini A
Int J Oncol; 1998 Apr; 12(4):899-903. PubMed ID: 9499453
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of CD146 as Target for Radioimmunotherapy against Osteosarcoma.
Westrøm S; Bønsdorff TB; Abbas N; Bruland ØS; Jonasdottir TJ; Mælandsmo GM; Larsen RH
PLoS One; 2016; 11(10):e0165382. PubMed ID: 27776176
[TBL] [Abstract][Full Text] [Related]
6. Significance of expression of human METCAM/MUC18 in nasopharyngeal carcinomas and metastatic lesions.
Lin JC; Chiang CF; Wang SW; Wang WY; Kwan PC; Wu GJ
Asian Pac J Cancer Prev; 2014; 15(1):245-52. PubMed ID: 24528033
[TBL] [Abstract][Full Text] [Related]
7. MiR-9 is overexpressed in spontaneous canine osteosarcoma and promotes a metastatic phenotype including invasion and migration in osteoblasts and osteosarcoma cell lines.
Fenger JM; Roberts RD; Iwenofu OH; Bear MD; Zhang X; Couto JI; Modiano JF; Kisseberth WC; London CA
BMC Cancer; 2016 Oct; 16(1):784. PubMed ID: 27724924
[TBL] [Abstract][Full Text] [Related]
8. Constitutive expression of non-bone/liver/kidney alkaline phosphatase in human osteosarcoma cell lines.
Ali NN; Rowe J; Teich NM
J Bone Miner Res; 1996 Apr; 11(4):512-20. PubMed ID: 8992882
[TBL] [Abstract][Full Text] [Related]
9. CD99 acts as an oncosuppressor in osteosarcoma.
Manara MC; Bernard G; Lollini PL; Nanni P; Zuntini M; Landuzzi L; Benini S; Lattanzi G; Sciandra M; Serra M; Colombo MP; Bernard A; Picci P; Scotlandi K
Mol Biol Cell; 2006 Apr; 17(4):1910-21. PubMed ID: 16421247
[TBL] [Abstract][Full Text] [Related]
10. ROCK2 deprivation leads to the inhibition of tumor growth and metastatic potential in osteosarcoma cells through the modulation of YAP activity.
Zucchini C; Manara MC; Cristalli C; Carrabotta M; Greco S; Pinca RS; Ferrari C; Landuzzi L; Pasello M; Lollini PL; Gambarotti M; Donati DM; Scotlandi K
J Exp Clin Cancer Res; 2019 Dec; 38(1):503. PubMed ID: 31878963
[TBL] [Abstract][Full Text] [Related]
11. Receptor binding of osteoblast-specific factor 1 (OSF-1/HB-GAM) to human osteosarcoma cells promotes cell attachment.
Gieffers C; Engelhardt W; Brenzel G; Matsuishi T; Frey J
Eur J Cell Biol; 1993 Dec; 62(2):352-61. PubMed ID: 7925491
[TBL] [Abstract][Full Text] [Related]
12. Surface proteomic analysis of osteosarcoma identifies EPHA2 as receptor for targeted drug delivery.
Posthumadeboer J; Piersma SR; Pham TV; van Egmond PW; Knol JC; Cleton-Jansen AM; van Geer MA; van Beusechem VW; Kaspers GJ; van Royen BJ; Jiménez CR; Helder MN
Br J Cancer; 2013 Oct; 109(8):2142-54. PubMed ID: 24064975
[TBL] [Abstract][Full Text] [Related]
13. CD146 expression in human breast cancer cell lines induces phenotypic and functional changes observed in Epithelial to Mesenchymal Transition.
Imbert AM; Garulli C; Choquet E; Koubi M; Aurrand-Lions M; Chabannon C
PLoS One; 2012; 7(8):e43752. PubMed ID: 22952755
[TBL] [Abstract][Full Text] [Related]
14. Characterization of osteosarcoma cell lines MG-63, Saos-2 and U-2 OS in comparison to human osteoblasts.
Pautke C; Schieker M; Tischer T; Kolk A; Neth P; Mutschler W; Milz S
Anticancer Res; 2004; 24(6):3743-8. PubMed ID: 15736406
[TBL] [Abstract][Full Text] [Related]
15. CD146, from a melanoma cell adhesion molecule to a signaling receptor.
Wang Z; Xu Q; Zhang N; Du X; Xu G; Yan X
Signal Transduct Target Ther; 2020 Aug; 5(1):148. PubMed ID: 32782280
[TBL] [Abstract][Full Text] [Related]
16. CD146 as a prognostic marker in breast cancer: A meta-analysis.
Sharma A; Somasundaram I; Chabaud MB
J Cancer Res Ther; 2024 Jan; 20(1):193-198. PubMed ID: 38554320
[TBL] [Abstract][Full Text] [Related]
17. CD146 expression is associated with a poor prognosis in human breast tumors and with enhanced motility in breast cancer cell lines.
Zabouo G; Imbert AM; Jacquemier J; Finetti P; Moreau T; Esterni B; Birnbaum D; Bertucci F; Chabannon C
Breast Cancer Res; 2009; 11(1):R1. PubMed ID: 19123925
[TBL] [Abstract][Full Text] [Related]
18. Long intergenic non-coding RNA 511 correlates with improved prognosis, and hinders osteosarcoma progression both in vitro and in vivo.
Qiao S; Qi K; Liu C; Xu C; Ma J; Xu X; Li C; Wang Z
J Clin Lab Anal; 2020 May; 34(5):e23164. PubMed ID: 31893577
[TBL] [Abstract][Full Text] [Related]
19. Raman spectroscopy for grading of live osteosarcoma cells.
Chiang YH; Wu SH; Kuo YC; Chen HF; Chiou A; Lee OK
Stem Cell Res Ther; 2015 Apr; 6(1):81. PubMed ID: 25928011
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical Expression of MCAM/CD146 in Canine Melanoma.
Abou Asa S
J Comp Pathol; 2017 Jul; 157(1):27-33. PubMed ID: 28735667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
